siRNA, Anti-HNF1A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21554WQ-2OMe)
The product SIRGT21554WQ-2OMe is a type of small interfering RNA (siRNA) that targets HNF1A gene and regulates the expression of gene. The siRNA interferes with the expression of HNF1A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_000545.6; NM_001306179.1 |
| Alternative Names | HNF-1A; HNF1; IDDM20; LFB1; MODY3; TCF-1; TCF1 |
| Related Diseases | Maturity onset diabetes of the young type 3 (MODY3) |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT22554WQ-2F | HNF1A | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT23554WQ-2MOE | HNF1A | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT24554WQ-LNA | HNF1A | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT21554WQ-RB | HNF1A | Human | Ribo-modified | ||
| SIRGT22554WQ-BB | HNF1A | Human | Backbone-modified |
